Researchers studied patients with Klebsiella pneumoniae carbapenemase-producing K. pneumoniae, or KPC-Kp, colonization or infection in an Australian hospital. The researchers examined the patients from January 2012 to September 2015.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox!
They found 34 cases of KPC-producing Enterobacteriaceae, including 31 KPC-Kp cases, and matched these with 136 control cases.
Variables associated with KPC-Kp acquisition included:
• Length of hospital stay greater than 28 days (within the past year)
• Prior vancomycin-resistant enterococci colonization
• Central venous catheter
• Gastrointestinal disease and invasive procedures
• Exposure to broad-spectrum antibiotics
Very few patients had a history of overseas travel, showing that “local screening strategies targeting overseas travelers would likely miss many cases,” the study authors concluded.
More articles on hospital quality:
Study: OR doors open approximately 13.4 times per hour during surgery, raising air particulate counts
Researchers tracked germs from Day 1 at a new hospital — here’s what they found
6 recent stories, studies on surgical site infections
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
